IL33 and obstructive sleep apnea syndrome: Sozer et al. (2018) reported serum IL-33 concentrations significantly higher in patients with OSA, and hypothesized that OSA influences the levels of IL-33 and is involved in the systemic inflammation produced in OSA [35].